Match tier Likely match
Presence Current · Arkansas
Last published 2024
Sources OpenAlex · ORCID
Refreshed 2026-10-03

Darby Derringer

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Role not yet determined Is this you? Add your title

2 h-index 3 pubs 427 cited

  • COVID-19
  • Organ Transplantation
  • SARS-CoV-2
  • Humans
  • Male
  • Middle Aged
  • Cohort Studies
  • Transplant Recipients

Biography and Research Information

OverviewAI-generated summary

Darby Derringer's research focuses on the health outcomes of organ transplant recipients, particularly in the context of viral infections. Their work has investigated the impact of COVID-19 on this patient population, examining factors such as delayed mortality and cohort characteristics. Derringer has also explored aspects of transplant recipient care, including the use of ideal body weight-based dosing for medications in obese kidney transplant recipients. Their scholarship metrics include an h-index of 2 and 426 total citations across 3 publications.

Metrics

  • h-index: 2
  • Publications: 3
  • Citations: 427

Selected Publications

  • Ideal Body Weight-Based Dosing of Rabbit Anti- Thymocyte Globulin in Obese Kidney Transplant Recipients: Cutting Costs Without Adding Risk (2024)
    Archives of Pharmacy & Pharmacology Research DOI OpenAlex

View all publications on OpenAlex →

Similar Researchers

Based on overlapping research topics